Entomologists review pros, cons and regulatory issues surrounding new technology that could help halt the spread of diseases such as Zika virus, dengue fever and malaria
Engineered gene drives, which have the potential to spread desirable genes throughout wild populations or to suppress harmful species, have received a lot of recent attention because of their potential to control organisms, such as mosquitoes that carry diseases such as Zika virus, malaria and dengue fever.
At the same time, the recently discovered CRISPR gene editing technology has the potential to create, streamline and improve the development of gene drives.
In a highly innovative and technical review, an entomologist at the University of California, Riverside has examined the different gene drives systems, analyzed the pros and cons of each and applications associated with them, and also surveyed the safety and regulatory issues associated with them.
“Despite all the potential benefits of gene drives, they remain understudied,” said Omar Akbari, an assistant professor of entomology at UC Riverside. “With that in mind, and with advances occurring so quickly, we wanted to step back and take a broad look at what is happening.”
Akbari, who is also a member of UC Riverside’s Center for Disease Vector Research andInstitute for Integrative Genome Biology, is the corresponding author of the piece, “Cheating evolution: engineering gene drives to manipulate the fate of wild populations,” that was just published online in the journal Nature Reviews Genetics. The piece was co-authored by Jackson Champer and Anna Buchman, both post-doctoral students working with Akbari.
The idea of editing the genes of organisms to address biological problems related to public and environmental health has been around for decades. In fact, the authors cite a paper from 1940 and others from the late 1960s that discuss this.
Despite the wide-ranging applicability and importance of gene drives, there has been only modest development in their progress in past decades. Gene drives capable of functioning in wild populations have been created in only a few organisms, including yeast, the fruitfly and two species of mosquitoes.
This is, in part, due to the difficulty of engineering the genomes of organisms. However, recent advancements have provided tools capable of engineering the genomes of diverse species. The most promising of these tools is CRISPR.
Combining gene drives and a tool such as CRISPR may enable the development of novel strategies to reduce or eliminate insect-borne diseases, remove invasive foreign species, and even reverse the development of resistance to insecticides and herbicides, in an economically viable and environmentally friendly manner.
In the paper, the authors focus on several types of gene drives, including homing-based drives, sex-linked meiotic drives, medea and underdominance gene drives. They describe the gene drives based on different attributes, including rate of spread, species specificity, fitness cost, susceptibility to resistance,removability and reversibility.
They also discuss whether the gene drives are classified as ‘modification drive’ types, which are designed to spread through a population carrying desirable traits, or as ‘suppression drive’ types, which have the effect of reducing the population of a target species.
Finally, the authors address safety and regulation. They mention dangers associated with gene drives, including the potential to cause extinctions, to spread outside a geographical area or traverse into another species and the potential misuse to cause economic damage or even bioterrorism.
Learn more: Engineered Gene Drives and the Future
The Latest on: Engineered gene drives
via Google News
The Latest on: Engineered gene drives
- China’s Genetics Giant Wants Everyone to Live to at Least 99on November 13, 2019 at 1:00 pm
Whole-genome sequencing, the technology that drives BGI’s business ... Weeks before, He said, the world’s first genetically engineered babies had been born on the mainland. Working in secret, he’d ...
- Editing disease in South Africaon November 12, 2019 at 7:05 am
Jankui crippled the production of the protein CCR5, which HIV uses to drive an infection. Germline editing has been ... cancer research is advancing each year—a patient's own immune cells can even now ...
- New CRISPR-Cas9 Protein can Increase Gene Editing Efficiencyon November 11, 2019 at 4:21 am
Variations of Cas9 have already been engineered to try and improve its specificity. However, these variations are still too big to comfortably fit inside the viral delivery vectors used to deliver the ...
- ZIOPHARM Oncology, Inc. (ZIOP) CEO Dr. Laurence Cooper on Q3 2019 Results - Earnings Call Transcripton November 10, 2019 at 3:41 pm
In the May 2019, IP license agreement, Ziopharm exclusively licensed in certain fields, intellectual property from the NCI to develop and commercialize autologous peripheral blood T cell therapy ...
- High-tech chestnuts: US to consider genetically altered treeon November 5, 2019 at 9:19 pm
The ESF American Chestnut Research & Restoration Project researchers have been able to add a gene to American chestnuts that give ... move that could expand the frontier for genetically engineered ...
- A Roadmap and Wish List for Synthetic Genomicson November 5, 2019 at 9:18 am
Within that huge world is an enormous variety of ideas and approaches, like custom-made proteins, CAR-T medicines, genetically engineered crops, and more. One sector still in its infancy is synthetic ...
- SPX Reports Third Quarter 2019 Resultson October 30, 2019 at 1:15 pm
Gene Lowe, President and CEO, commented ... With our strong balance sheet, we also remain well-positioned to deploy capital to drive shareholder value, including for highly strategic acquisitions, ...
- Allogene Therapeutics: Stay On The Sidelines On This Until 2020on October 29, 2019 at 10:48 am
The highly personalized nature of autologous CAR-Ts have made scaling up production a challenge which in turn drives up costs. The challenges of autologous ... To further enhance the expansion and ...
- Is there a responsible way forward for gene editing?on October 29, 2019 at 4:15 am
Although the U.S. has no outright ban on editing the genes of human embryos, a restrictive regulatory landscape and a lack of federal support has imposed significant restrictions on researchers.
- Breakthrough gene-editing tool can find and replace DNA better than CRISPRon October 21, 2019 at 8:02 am
The ability to edit the genes of human beings by changing the code of life ... an enzyme that can "write" the DNA code letter by letter. They join this with an engineered guide RNA, which tells the ...
via Bing News